Insurance data can help fill gaps between longer medical trials for patients up against the clock

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

TrialAssure Establishes Presence in The Netherlands to Advance Clinical Trial Transparency, Data Sharing Across Europe

TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced ...

BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease

Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone -- Topline Results ...

Positive China Trial Data Moves HUTCHMED Closer To Rare Blood Disorder Drug Filing In 2026

HUTCHMED reported positive Phase 3 trial results for sovleplenib in autoimmune anemia, supporting a planned China drug filing ...

Allucent executives on leveraging AI, emerging tech to accelerate clinical trials for small and mid-size biopharma innovators

Allucent has strategically added executives to its C-suite and is deploying artificial intelligence tools to help small and ...
Pancreatic Cancer Action Network

Questions About Clinical Trials? The PanCAN Patient Services Team Can Help

The PanCAN Patient Services team is here for patients and their loved ones as they navigate clinical trials. Our Case Managers offer personal, one-to-one support at every step of the search and ...
Nature

Analysis of phase II and phase III clinical trial terminations from 2013 to 2023

Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Disc. 23, 656–657; 2024). With the ...